151 related articles for article (PubMed ID: 27875522)
21. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
22. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
Kieran MW; Chisholm J; Casanova M; Brandes AA; Aerts I; Bouffet E; Bailey S; Leary S; MacDonald TJ; Mechinaud F; Cohen KJ; Riccardi R; Mason W; Hargrave D; Kalambakas S; Deshpande P; Tai F; Hurh E; Geoerger B
Neuro Oncol; 2017 Oct; 19(11):1542-1552. PubMed ID: 28605510
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
Yamamoto K; Iwahana M; Kumazawa E; Kakihata K; Abe K; Hirano F; Tohgo A; Hoshiai H; Noda K
Oncol Rep; 2003; 10(3):593-8. PubMed ID: 12684629
[TBL] [Abstract][Full Text] [Related]
25. Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.
Knecht R; Peters S; Adunka O; Strebhardt K; Gstoettner W; Hambek M
Anticancer Res; 2003; 23(3B):2577-83. PubMed ID: 12894544
[TBL] [Abstract][Full Text] [Related]
26. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model.
Chaudary N; Mujcic H; Wouters BG; Hill RP
Radiother Oncol; 2013 Sep; 108(3):506-10. PubMed ID: 23856487
[TBL] [Abstract][Full Text] [Related]
28. Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
[TBL] [Abstract][Full Text] [Related]
29. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
[TBL] [Abstract][Full Text] [Related]
30. Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling.
Michaud NR; Wang Y; McEachern KA; Jordan JJ; Mazzola AM; Hernandez A; Jalla S; Chesebrough JW; Hynes MJ; Belmonte MA; Wang L; Kang JS; Jovanovic J; Laing N; Jenkins DW; Hurt E; Liang M; Frantz C; Hollingsworth RE; Simeone DM; Blakey DC; Bedian V
Mol Cancer Ther; 2014 Feb; 13(2):386-98. PubMed ID: 24344235
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.
Qi L; Lindsay H; Kogiso M; Du Y; Braun FK; Zhang H; Guo L; Zhao S; Injac SG; Baxter PA; Su JM; Xiao S; Erickson SW; Earley EJ; Teicher B; Smith MA; Li XN
Lab Invest; 2022 Feb; 102(2):185-193. PubMed ID: 34802040
[TBL] [Abstract][Full Text] [Related]
32. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
33. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
34. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.
Chen L; Silapunt S; Migden MR
Future Oncol; 2016 Sep; 12(18):2095-105. PubMed ID: 27189494
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
Sims-Mourtada J; Izzo JG; Apisarnthanarax S; Wu TT; Malhotra U; Luthra R; Liao Z; Komaki R; van der Kogel A; Ajani J; Chao KS
Clin Cancer Res; 2006 Nov; 12(21):6565-72. PubMed ID: 17085672
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial of weekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in treatment of locally advanced cervical cancer: in regard to Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581).
Chakraborty S; Patil N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320-1. PubMed ID: 22385716
[No Abstract] [Full Text] [Related]
37. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.
Chaudary N; Pintilie M; Hedley D; Fyles AW; Milosevic M; Clarke B; Hill RP; Mackay H
Cancer; 2012 Jun; 118(12):3105-15. PubMed ID: 22028038
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Nogueira-Rodrigues A; do Carmo CC; Viegas C; Erlich F; Camisão C; Fontão K; Lima R; Herchenhorn D; Martins RG; Moralez GM; Small IA; Ferreira CG
Clin Cancer Res; 2008 Oct; 14(19):6324-9. PubMed ID: 18829516
[TBL] [Abstract][Full Text] [Related]
39. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer: in regard to Sang-Young Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581).
Goel S; Mitra S; Rawat S; Sharma SK; Sharma MK; Bhutani R; Kakria A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320. PubMed ID: 22385715
[No Abstract] [Full Text] [Related]
40. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
